Compounds > 2-hexynyladenosine-5'-n-ethylcarboxamide
Page last updated: 2024-09-05

2-hexynyladenosine-5'-n-ethylcarboxamide and mre 3008-f20

2-hexynyladenosine-5'-n-ethylcarboxamide has been researched along with mre 3008-f20 in 1 studies

Compound Research Comparison

Studies
(2-hexynyladenosine-5'-n-ethylcarboxamide)		Trials
(2-hexynyladenosine-5'-n-ethylcarboxamide)		Recent Studies (post-2010)
(2-hexynyladenosine-5'-n-ethylcarboxamide)		Studies
(mre 3008-f20)		Trials
(mre 3008-f20)		Recent Studies (post-2010) (mre 3008-f20)
28022708

Protein Interaction Comparison

ProteinTaxonomy2-hexynyladenosine-5'-n-ethylcarboxamide (IC50)mre 3008-f20 (IC50)
Adenosine receptor A3Homo sapiens (human)0.0048

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baraldi, PG; Benini, A; Borea, PA; Cattabriga, E; Gessi, S; Klotz, KN; Lennan, SM; Leung, E; Merighi, S; Tabrizi, MA; Varani, K; Vincenzi, F1

Other Studies

1 other study(ies) available for 2-hexynyladenosine-5'-n-ethylcarboxamide and mre 3008-f20

ArticleYear
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors.
    Biochemical pharmacology, 2005, Nov-25, Volume: 70, Issue:11

    Topics: Adenosine; Adenosine A2 Receptor Antagonists; Animals; Binding, Competitive; Cell Line; Cyclic AMP; Humans; Molecular Structure; Protein Binding; Receptor, Adenosine A2B; Recombinant Proteins

2005